Cargando…

Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer

Available tests to detect clinically significant prostate cancer frequently lead to overdiagnosis and overtreatment. Our study assessed the feasibility of combining a urinary biomarker-based risk score (SelectMDx(®)) and multiparametric MRI outcomes in order to identify patients with prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katzendorn, Olga, von Klot, Christoph A. J., Mahjoub, Samy, Faraj Tabrizi, Pouriya, Harke, Nina N., Tezval, Hossein, Hellms, Susanne, Hennenlotter, Jörg, Baig, Mirza S., Stenzl, Arnulf, Seith, Ferdinand, Lafos, Marcel, Kuczyk, Markus A., Rausch, Steffen, Peters, Inga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374213/ https://www.ncbi.nlm.nih.gov/pubmed/35960727 http://dx.doi.org/10.1371/journal.pone.0271981

Ejemplares similares

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
por: Katzendorn, Olga, et al.
Publicado: (2021)

DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma
por: Katzendorn, Olga, et al.
Publicado: (2021)

Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients
por: Mazdak, Mehrdad, et al.
Publicado: (2021)

Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS)
por: Serth, Jürgen, et al.
Publicado: (2022)

Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Carcinoma
por: Faraj Tabrizi, Pouriya, et al.
Publicado: (2023)

Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue
por: Serth, Jürgen, et al.
Publicado: (2020)

Spider silk erectile nerve reconstruction in robot-assisted radical prostatectomy: a first-in-men feasibility analysis
por: Harke, Nina N., et al.
Publicado: (2023)

Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis
por: Tezval, Hossein, et al.
Publicado: (2016)

Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer
por: Tezval, Hossein, et al.
Publicado: (2013)

Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma
por: Peters, Inga, et al.
Publicado: (2014)

Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response
por: Dubrowinskaja, Natalia, et al.
Publicado: (2014)

Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma
por: von Klot, Christoph-A, et al.
Publicado: (2014)

GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma
por: PETERS, INGA, et al.
Publicado: (2014)

Hemopatch(®) as a Hemostatic Agent is Safe in Partial Nephrectomy: A Large, Single-Surgeon Retrospective Evaluation
por: Hupe, Marie C., et al.
Publicado: (2020)

Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)
por: Nicklas, André P., et al.
Publicado: (2018)

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
por: Büttner, Florian, et al.
Publicado: (2018)

Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
por: Gebauer, K, et al.
Publicado: (2013)

Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases
por: Aufderklamm, Stefan, et al.
Publicado: (2021)

Surgical approach in patients with T4 bladder cancer as primary treatment: Disaster or option with improved quality of life
por: Nagele, Udo, et al.
Publicado: (2008)

Assessment of a new point-of-care system for detection of prostate specific antigen
por: Rausch, Steffen, et al.
Publicado: (2016)

Perinephric Toxic Fat: Impact on Surgical Complexity, Perioperative Outcome, and Surgical Approach in Partial Nephrectomy
por: Walach, Margarete Teresa, et al.
Publicado: (2023)

Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer
por: Waalkes, Sandra, et al.
Publicado: (2010)

Tomographic score (RAD-Covid Score) to assess the clinical severity of the novel coronavirus infection
por: Ribeiro, Tatiana Figueiredo Guimarães, et al.
Publicado: (2021)

VI-RADS score system - A primer for urologists
por: Nicola, Refky, et al.
Publicado: (2022)

Systemic Alterations of Wnt Inhibitors in Patients with Prostate Cancer and Bone Metastases
por: Aufderklamm, Stefan, et al.
Publicado: (2018)

Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases
por: Maas, Moritz, et al.
Publicado: (2023)

PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both
por: Tezval, Hossein, et al.
Publicado: (2021)

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy
por: von Klot, Christoph A., et al.
Publicado: (2017)

First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study
por: Peters, Inga, et al.
Publicado: (2023)

Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?
por: Bier, Simone, et al.
Publicado: (2018)

Diagnostic performance of the EU TI‐RADS and ACR TI‐RADS scoring systems in predicting thyroid malignancy
por: Chatti, Hiba‐Allah, et al.
Publicado: (2023)

Age-Related DNA Methylation in Normal Kidney Tissue Identifies Epigenetic Cancer Risk Susceptibility Loci in the ANKRD34B and ZIC1 Genes
por: Serth, Jürgen, et al.
Publicado: (2022)

Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation
por: Stickel, Juliane S, et al.
Publicado: (2011)

MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
por: Fisel, Pascale, et al.
Publicado: (2015)

Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2014)

Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2015)

Validity of STONE Score in Clinical Prediction of Ureteral Stone Disease
por: Malik, Abdul, et al.
Publicado: (2020)

Prospective evaluation of fluorescence-guided cystoscopy to detect bladder cancer in a high-risk population: results from the UroScreen-Study
por: Horstmann, Marcus, et al.
Publicado: (2014)

Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus Nivolumab
por: Stühler, Viktoria, et al.
Publicado: (2022)

Real world data on IO-based therapy for metastatic renal cell carcinoma
por: Stühler, Viktoria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c46deu3r4d5viqhba07uudlaqm